What are predictors of risk progression and/or poor therapeutic response in RA that would make a patient appropriate for early, aggressive therapy with biologic therapy?

What are predictors of risk progression and/or poor therapeutic response in RA that would make a patient appropriate for early, aggressive therapy with biologic therapy?

What are predictors of risk progression and/or poor therapeutic response in RA that would make a patient appropriate for early, aggressive therapy with biologic therapy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Jonathan Kay, MD

Jonathan Kay, MD

Director of Clinical Research
Rheumatology Division
Professor of Medicine
University of Massachusetts Medical School
Worcester, MA